Range Impact (RNGE) 10-K2020 FY Annual report

Filed: 29 Jun 20, 4:06pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Avg

New words: annum, breadth, CECL, Combinationsand, conserve, constituted, COSO, distancing, economy, Emmett, feedback, forgiven, guidanceClarification, hypothetical, implicit, incremental, InMay, jointly, Kaurenoic, kit, length, loan, OOPD, open, operationally, outbreak, pandemic, payroll, pursing, rapidly, rationale, readily, reclassified, Rocklin, ROU, Sierra, sought, spread, subpopulation, subset, USPTO, validity, virtually

Removed: absolute, abstained, agricultural, aim, Anthony, applied, appoint, assured, attestation, bad, began, Biology, biopharmaceutical, cancer, CancerVax, Carlson, cell, central, chemical, circumvented, Clara, collectability, collected, collusion, combined, compensating, conceived, conclusion, confidence, consultant, DataPlan, DC, Delaware, description, detect, disability, discussed, document, doubtful, earliest, employee, expend, exploration, extended, faulty, feature, fifty, forfeited, forfeiture, formal, fourth, GS, Immunology, implementing, inExchange, inInternal, integrity, Jose, journal, lapse, largest, Lockheed, manager, membership, metastatic, mineral, MSD, network, Northwest, occurred, oncology, override, participation, passed, people, periodically, PharmaNet, post, posting, preclinical, presence, principle, realization, realized, recipient, reducing, reliance, remediate, repayment, Replicon, reselling, revised, San, Santa, science, simple, Society, speaker, spectrum, SPPI, strain, testimony, therapy, Treasurer, uncollectible, unused, unvested, venture, view

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

RNGE similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, Michael Cavanaugh, the Chief Executive Officer of Vitality Biopharma, Inc. (the “Company”), hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge, the Annual Report on Form 10-K for the period ended March 31, 2020, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in the Annual Report on Form 10-K fairly presents in all material respects the financial condition and results of operations of the Company.

/s/ Michael Cavanaugh
Chief Executive Officer
(Principal Executive Officer)
Date: June 29, 2020